DTaP and Tdap Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global DTaP and Tdap Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the DTaP and Tdap Vaccines market is segmented into
DTaP
Td
Tdap
Segment by Application, the DTaP and Tdap Vaccines market is segmented into
Adult
Pediatric
Regional and Country-level Analysis
The DTaP and Tdap Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the DTaP and Tdap Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and DTaP and Tdap Vaccines Market Share Analysis
DTaP and Tdap Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in DTaP and Tdap Vaccines business, the date to enter into the DTaP and Tdap Vaccines market, DTaP and Tdap Vaccines product introduction, recent developments, etc.
The major vendors covered:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
1 Study Coverage
1.1 DTaP and Tdap Vaccines Product Introduction
1.2 Market Segments
1.3 Key DTaP and Tdap Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Type
1.4.2 DTaP
1.4.3 Td
1.4.4 Tdap
1.5 Market by Application
1.5.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Application
1.5.2 Adult
1.5.3 Pediatric
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global DTaP and Tdap Vaccines Market Size, Estimates and Forecasts
2.1.1 Global DTaP and Tdap Vaccines Revenue 2015-2026
2.1.2 Global DTaP and Tdap Vaccines Sales 2015-2026
2.2 Global DTaP and Tdap Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 DTaP and Tdap Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 DTaP and Tdap Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global DTaP and Tdap Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global DTaP and Tdap Vaccines Revenue Forecast by Region (2021-2026)
3 Global DTaP and Tdap Vaccines Competitor Landscape by Players
3.1 Global Top DTaP and Tdap Vaccines Sales by Manufacturers
3.1.1 Global DTaP and Tdap Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global DTaP and Tdap Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global DTaP and Tdap Vaccines Manufacturers by Revenue
3.2.1 Global DTaP and Tdap Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global DTaP and Tdap Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global DTaP and Tdap Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by DTaP and Tdap Vaccines Revenue in 2019
3.2.5 Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global DTaP and Tdap Vaccines Price by Manufacturers
3.4 Global DTaP and Tdap Vaccines Manufacturing Base Distribution, Product Types
3.4.1 DTaP and Tdap Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers DTaP and Tdap Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into DTaP and Tdap Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global DTaP and Tdap Vaccines Market Size by Type (2015-2020)
4.1.1 Global DTaP and Tdap Vaccines Sales by Type (2015-2020)
4.1.2 Global DTaP and Tdap Vaccines Revenue by Type (2015-2020)
4.1.3 DTaP and Tdap Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global DTaP and Tdap Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 DTaP and Tdap Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global DTaP and Tdap Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global DTaP and Tdap Vaccines Market Size by Application (2015-2020)
5.1.1 Global DTaP and Tdap Vaccines Sales by Application (2015-2020)
5.1.2 Global DTaP and Tdap Vaccines Revenue by Application (2015-2020)
5.1.3 DTaP and Tdap Vaccines Price by Application (2015-2020)
5.2 DTaP and Tdap Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global DTaP and Tdap Vaccines Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
6.1.1 China DTaP and Tdap Vaccines Sales YoY Growth 2015-2026
6.1.2 China DTaP and Tdap Vaccines Revenue YoY Growth 2015-2026
6.1.3 China DTaP and Tdap Vaccines Market Share in Global Market 2015-2026
6.2 China DTaP and Tdap Vaccines Market Size by Players (International and Local Players)
6.2.1 China Top DTaP and Tdap Vaccines Players by Sales (2015-2020)
6.2.2 China Top DTaP and Tdap Vaccines Players by Revenue (2015-2020)
6.3 China DTaP and Tdap Vaccines Historic Market Review by Type (2015-2020)
6.3.1 China DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
6.3.2 China DTaP and Tdap Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 China DTaP and Tdap Vaccines Price by Type (2015-2020)
6.4 China DTaP and Tdap Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China DTaP and Tdap Vaccines Sales Forecast by Type (2021-2026)
6.4.2 China DTaP and Tdap Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 China DTaP and Tdap Vaccines Price Forecast by Type (2021-2026)
6.5 China DTaP and Tdap Vaccines Historic Market Review by Application (2015-2020)
6.5.1 China DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
6.5.2 China DTaP and Tdap Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 China DTaP and Tdap Vaccines Price by Application (2015-2020)
6.6 China DTaP and Tdap Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China DTaP and Tdap Vaccines Sales Forecast by Application (2021-2026)
6.6.2 China DTaP and Tdap Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 China DTaP and Tdap Vaccines Price Forecast by Application (2021-2026)
7 North America
7.1 North America DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
7.2 North America DTaP and Tdap Vaccines Market Facts & Figures by Country
7.2.1 North America DTaP and Tdap Vaccines Sales by Country (2015-2020)
7.2.2 North America DTaP and Tdap Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
8.2 Europe DTaP and Tdap Vaccines Market Facts & Figures by Country
8.2.1 Europe DTaP and Tdap Vaccines Sales by Country
8.2.2 Europe DTaP and Tdap Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific DTaP and Tdap Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific DTaP and Tdap Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific DTaP and Tdap Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America DTaP and Tdap Vaccines Market Facts & Figures by Country
10.2.1 Latin America DTaP and Tdap Vaccines Sales by Country
10.2.2 Latin America DTaP and Tdap Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa DTaP and Tdap Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa DTaP and Tdap Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Country
11.2.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Sanofi Pasteur
12.1.1 Sanofi Pasteur Corporation Information
12.1.2 Sanofi Pasteur Description and Business Overview
12.1.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
12.1.5 Sanofi Pasteur Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Protein Sciences Corporation
12.3.1 Protein Sciences Corporation Corporation Information
12.3.2 Protein Sciences Corporation Description and Business Overview
12.3.3 Protein Sciences Corporation Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Products Offered
12.3.5 Protein Sciences Corporation Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Corporation Information
12.4.2 Novartis AG Description and Business Overview
12.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis AG DTaP and Tdap Vaccines Products Offered
12.4.5 Novartis AG Recent Development
12.5 Seqirus
12.5.1 Seqirus Corporation Information
12.5.2 Seqirus Description and Business Overview
12.5.3 Seqirus Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Seqirus DTaP and Tdap Vaccines Products Offered
12.5.5 Seqirus Recent Development
12.6 Merck Sharp & Dohme Corp
12.6.1 Merck Sharp & Dohme Corp Corporation Information
12.6.2 Merck Sharp & Dohme Corp Description and Business Overview
12.6.3 Merck Sharp & Dohme Corp Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Products Offered
12.6.5 Merck Sharp & Dohme Corp Recent Development
12.7 Astellas Pharma US, Inc
12.7.1 Astellas Pharma US, Inc Corporation Information
12.7.2 Astellas Pharma US, Inc Description and Business Overview
12.7.3 Astellas Pharma US, Inc Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Products Offered
12.7.5 Astellas Pharma US, Inc Recent Development
12.8 Pfizer Inc
12.8.1 Pfizer Inc Corporation Information
12.8.2 Pfizer Inc Description and Business Overview
12.8.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer Inc DTaP and Tdap Vaccines Products Offered
12.8.5 Pfizer Inc Recent Development
12.9 Johnson & Johnson
12.9.1 Johnson & Johnson Corporation Information
12.9.2 Johnson & Johnson Description and Business Overview
12.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Johnson & Johnson DTaP and Tdap Vaccines Products Offered
12.9.5 Johnson & Johnson Recent Development
12.10 Lanzhou Institute of Biological Products Co., Ltd
12.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
12.10.2 Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
12.10.3 Lanzhou Institute of Biological Products Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Products Offered
12.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Development
12.11 Sanofi Pasteur
12.11.1 Sanofi Pasteur Corporation Information
12.11.2 Sanofi Pasteur Description and Business Overview
12.11.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
12.11.5 Sanofi Pasteur Recent Development
12.12 Emergent BioSolutions Inc
12.12.1 Emergent BioSolutions Inc Corporation Information
12.12.2 Emergent BioSolutions Inc Description and Business Overview
12.12.3 Emergent BioSolutions Inc Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Emergent BioSolutions Inc Products Offered
12.12.5 Emergent BioSolutions Inc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key DTaP and Tdap Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 DTaP and Tdap Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
*If Applicable.